Research status of targeted drug and whole brain radiotherapy for non-small cell lung cancer with brain metastasis
10.3760/cma.j.issn.1673-422X.2016.03.015
- VernacularTitle:靶向药物和全脑放疗治疗非小细胞肺癌脑转移的研究现状
- Author:
Xiaolei WANG
;
Lin AN
;
Deze LIU
- Publication Type:Journal Article
- Keywords:
Carcinoma,non-small-cell lung;
Neoplasm metastasis;
Radiotherapy;
Targeted therapy
- From:
Journal of International Oncology
2016;43(3):216-219
- CountryChina
- Language:Chinese
-
Abstract:
Whole brain radiation therapy has become the standard treatment of non-small cell lung cancer (NSCLC) with brain metastasis,because it prolongs the survival times of NSCLC patients with brain metastases.The emergence of molecular targeted drugs is a major innovation in the traditional sense of the cancer treatment.Molecular targeted drugs have many advantages such as convenient dosing,rapid onset,improving the intracranial and extracranial tumor lesions at the same time,mild adverse reactions and good tolerance,which provide a new and better choice for the treatment of NSCLC patients with brain metastases.
